..
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City
California
94404
U.S.A.
Phone:
800-GILEAD-5 or 650-574-3000
Fax:
650-522-5800
|
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
Key Contacts:
John C. Martin, PhD, Chairman and Chief Executive Officer
John F. Milligan, PhD, President and Chief Operating Officer
Norbert W. Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer
Kevin Young, Executive Vice President, Commercial Operations
Gregg Alton, Executive Vice President, Corporate and Medical Affairs
Kristen Metza, Senior Vice President, Human Resources
Robin Washington, Senior Vice President and Chief Financial Officer
Susan Hubbard, Vice President, Investor Relations
Amy Flood, Vice President, Public Affairs
Email:
Ownership:
Public
Web Site:
Gilead Sciences, Inc.
Employees:
4,000
Symbol: GILD
|
|
|
Company News |
Gilead Sciences, Inc. (GILD) Prices $4 Billion Of Senior Unsecured Notes
3/5/2014 6:28:29 AM
More...
|
Gilead Sciences, Inc. (GILD) Chief Becomes Billionaire On $84,000 Hepatitis Drug
3/4/2014 8:01:00 AM
More...
|
Gilead Sciences, Inc. (GILD) To Present At The 34th Cowen and Company Healthcare Conference On Monday, March 3
3/3/2014 7:21:31 AM
More...
|
Gilead Sciences, Inc. (GILD)To Present at the RBC Capital Markets 2014 Global Healthcare Conference On Wednesday, February 26
2/26/2014 6:52:47 AM
More...
|
Gilead Sciences, Inc. (GILD) Close To Dominating Second Multibillion Market With Solvadi
2/21/2014 8:29:28 AM
More...
|
CURx Pharmaceuticals Snags Rights To Gilead Sciences, Inc. (GILD)'s Lung Infection Drug
2/19/2014 10:19:53 AM
More...
|
AHF: Gilead Sciences, Inc. (GILD)’s $1,000 Hepatitis C Pill Target Of SF, NYC Protests Feb.12th
2/12/2014 9:52:09 AM
More...
|
Actelion Ltd. (ALIOF.PK)'s Lung Drug May Face Study Against Gilead Sciences, Inc. (GILD) Rival
2/12/2014 8:12:49 AM
More...
|
Gilead Sciences, Inc. (GILD) COO: Analysts' Sky-High Hep C Drug View "Not Unreasonable"
2/12/2014 7:15:36 AM
More...
|
Gilead Sciences, Inc. (GILD) To Present At Two Upcoming Investor Conferences
2/11/2014 8:42:24 AM
More...
|
|
|
|